Navigation Links
Elecsys® proBNP

ProductsElecsys® proBNP
Company Roche Diagnostics
Item Elecsys® proBNP
Features 
  • Fully automated quantification of NT-proBNP - The Elecsys proBNP assay provides quantification of the N-terminal prohormone of B-type natriuretic peptide (NT-proBNP), a direct marker for ventricular (dys)function, without interference from certain drug therapies. It is fully automated and compatible with routine laboratory testing.
  • Rapid results - Results are ready to report to physicians in as little as 18 minutes using serum or plasma (heparin, EDTA) samples, providing fast, actionable healthcare information.
  • Cost-effective diagnosis and therapy - Elecsys proBNP helps to identify patients requiring further cardiac assessment, leading to more cost-effective use of echocardiography.
  • Improvement of patient management - Quantification of NT-proBNP helps to identify high risk patients (e.g. mortality, re-hospitalization) which may require more intensive care. Monitoring of NT-proBNP levels may also help to optimize or tailor patient's therapy" to avoid over- or under-treatment.
Description A fast, reliable and accurate immunoassay for the quantification of NT-proBNP in serum and plasma. The fully automated Elecsys proBNP assay helps to rule-out efficiently heart failure in symptomatic patients. NT-proBNP levels also indicate the severity of the disease and allow the assessment of prognosis. In addition, NT-proBNP facilitates monitoring, allowing for the optimization and fine-tuning of treatment.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. CARDIAC proBNP Test
2. StatusFirst™ CHF NT-proBNP
... Antibodies (ANAs) has long been an important ... diseases. The antigens used in their detection ... human or animal nuclei, this has led ... (ENAs). The most commonly measured ENA specifications ...
Enzyme-linked immunosorbent assays for the detection and quantitation of IgG antibodies to extractable nuclear antigens (ENA) Sm in human serum.Antibodies to Sm aid in the diagnosis of systemic lupus...
... assays for the detection and ... extractable nuclear antigens (ENA) SS-B ... (Ro) and SS-B (La) antibodies ... SLE, subacute cutaneous lupus erythematosus ...
... assays for the detection and ... extractable nuclear antigens (ENA)RNP, Sm ... Sm aid in the diagnosis ... ,RNP antibodies aid in the ...
Medicine Products:
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology: